1. Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs.
- Author
-
Watanabe, Masato, Nakamoto, Keitaro, Inui, Toshiya, Sada, Mitsuru, Chibana, Kazuyuki, Miyaoka, Chika, Yoshida, Yuki, Aso, Jumpei, Nunokawa, Hiroki, Honda, Kojiro, Nakamura, Masuo, Tamura, Masaki, Hirata, Aya, Oda, Miku, Takata, Saori, Saraya, Takeshi, Kurai, Daisuke, Ishii, Haruyuki, and Takizawa, Hajime
- Subjects
PNEUMONIA - Abstract
Keywords: asthma; asthma-COPD overlap; COPD; neutrophil; sputum EN asthma asthma-COPD overlap COPD neutrophil sputum 3137 3141 5 09/30/22 20221001 NES 221001 Soluble suppression of tumorigenicity 2 (sST2) is a decoy receptor for interleukin 33 (IL-33). Soluble ST2 enhances IL-33-induced neutrophilic and pro-type 2 inflammation in the lungs (C-E) Scatter plots of sST2 and IL-33 (C), IL-33 and chemokine (D), and sST2 and chemokine (E) levels in sputum from the same patients. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF